首页 | 本学科首页   官方微博 | 高级检索  
     


Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
Authors:Jun Li  Han Zhang  Peng Sun  Feng Gu  Zhe-Li Liu
Affiliation:Department of Ophthalmology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China;Department of Ophthalmology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China;Department of Ophthalmology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China;Department of Ophthalmology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China;Department of Ophthalmology, the First Affiliated Hospital of China Medical University, Shenyang 110001, Liaoning Province, China
Abstract:
Keywords:age-related macular degeneration   choroidal neovascularization   bevacizumab (avastin)   ranibizumab (lucentis)
点击此处可从《国际眼科》浏览原始摘要信息
点击此处可从《国际眼科》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号